Don’t be afraid to identify blood diseases, which are clinically curable!

Blood diseases are a group of diseases involving blood and blood-forming tissues that may affect the functioning of red cells, white cells, slabs, or involve abnormalities in blood condensation and leukemia formation. Although there are many types of blood diseases, some of them do have high clinically curable rates. The following are some of the treatments for blood diseases with high rates:Acute lymphocyte leukemia (ALL)Acute lymphocyte leukaemia is the most common type of leukaemia among children and adolescents. Through the modern combination of chemotherapy programmes, the cure rate for all has increased significantly, especially for children, which can reach 80 to 90 per cent. Treatment usually includes induction, consolidation and maintenance of chemotherapy, and sometimes stem blood cell transplants.Chronic Particle Leukemia (CML)The treatment of chronic pulmonary leukaemia has made significant progress over the past decades. The availability of target drugs such as Imatinib (TKI) has led to a significant increase in the long-term survival of CML, even for a period similar to normal life. Many patients are able to achieve deep molecular relief after taking TKI.MSDAnomalous syndrome of bone marrow amplification is a group of amphibious cloned stem cell diseases. Although the treatment of MDS is more complex, some of the low-risk MDS patients can be mitigated through immunosuppressive treatment or haematological growth. For patients suitable for transplantation, stem blood cell transplants are a potential cure.LymphomaHodgkin lymphoma and non-Hodgkin lymphoma are all blood cancers that can be cured by chemotherapy, decomposition and immunotherapy. The rate of treatment of lymphoma in Hocking is between 70 and 90 per cent, while that of common non-Hodgkin lymphoma, such as the prevalence of large B cell lymphoma, can also reach 60 to 70 per cent.Decreasing IPPDecreasing cystasy is an autoimmune disease, characterized by a reduction in the number of sphygmomanometers. Although ITP is not usually lethal, most patients can be treated with sugar cortex hormones, immunosuppressants, spleen removal, etc.Mediterranean anaemiathalassaemia is a genetic hemoglobin synthesis disorder. Patients with moderate thalassaemia may not require special treatment, while those with severe thalassaemia can sustain their lives through regular blood transfusions and iron sequestration. For the right patients, blood stem cell transplants are the only possible cure.Genetic spherical cell amplificationIt is a genetic red membrane disease that results in a spherical form of red cells. Spleen removal is an effective way of treating genetically spherical cell amplification, and most patients can return to normal life after surgery.Overview of treatment:Chemotherapy: The use of chemical drugs to kill or inhibit the growth of cancer cells is applicable to multiple blood cancers.Demobilization: use of high-energy rays to kill cancer cells or reduce tumours, often for diseases such as lymphoma.Target treatment: Molecular targets for cancer cells, such as TKI for CML, are used with specific drugs.Immunization treatment: use of the patient ‘ s own immune system or immuno-regulatory drugs to attack cancer cells.Blood stem cell transplant: Re-establishment of the patient ‘ s blood and immune system by transplanting healthy stem blood cells.In the face of blood-borne diseases, patients should remain positive and optimistic, receive timely medical treatment and follow medical advice. With advances in medical science and technology, an increasing number of patients with blood diseases are expected to be cured. At the same time, the patient should take care to adjust his/her lifestyle, maintain a good nutritional status and increase his/her physical immunity, in order to better coordinate his/her treatment.